Weiss Ratings Reiterates “Sell (E+)” Rating for VSee Health (NASDAQ:VSEE)

VSee Health (NASDAQ:VSEE)‘s stock had its “sell (e+)” rating reissued by research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

VSee Health Trading Up 4.4%

Shares of VSEE opened at $0.70 on Wednesday. The business’s fifty day simple moving average is $0.79 and its two-hundred day simple moving average is $1.05. VSee Health has a 12 month low of $0.58 and a 12 month high of $3.54.

Institutional Trading of VSee Health

Several institutional investors have recently added to or reduced their stakes in the business. XTX Topco Ltd purchased a new position in shares of VSee Health in the 1st quarter worth $34,000. Osaic Holdings Inc. boosted its stake in shares of VSee Health by 197.5% in the 2nd quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock worth $52,000 after buying an additional 29,985 shares during the last quarter. Finally, HB Wealth Management LLC purchased a new position in shares of VSee Health in the 1st quarter worth $723,000. 1.01% of the stock is currently owned by hedge funds and other institutional investors.

About VSee Health

VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.